BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 14, 2019
View Archived Issues
Macrophage-glioma cell interactions can be targeted for PTEN-null glioma
Read More
Potential of targeting the miR-21/Wnt/CD44v6 pathway in ovarian cancer
Read More
Pharmacological stabilization of TYK2 kinase could treat multiple immune-mediated diseases
Read More
Fecal transplants for pancreatic cancer?
Read More
High-throughput method for discovering gene interactions
Read More
IFN punctures BBB
Read More
A neutralizing H7N9 Ab isolated from an infected patient kills infected cells and confers protection
Read More
CEPI and PHV enter partnering agreement for development of rVSV-Nipah vaccine candidate
Read More
Shanghai Institute of Materia Medica and Suzhou Suplead Life Sciences patent BRD4 inhibitors
Read More
New beta-secretase inhibitors synthesized at Novartis
Read More
Medshine Discovery presents new antibacterials
Read More
New mGluR5 allosteric modulators discovered at Recordati Industria Chimica e Farmaceutica
Read More
Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616
Read More
DS-39201083 is a new derivative of conolidine with superior analgesic activity
Read More
SHR-1653 as a novel highly potent and selective OTR antagonist
Read More
Pharmadiall presents new coagulation factor Xa inhibitors
Read More
AC Immune partners with University of Pennsylvania to further study TDP-43
Read More
CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases
Read More
DelMar reports updated results from phase II study of VAL-083 in newly diagnosed GBM
Read More
Enrollment ongoing in phase III study of tucatinib plus T-DM1 in HER2+ breast cancer
Read More
European Commission approves ibrutinib for expanded use in two indications
Read More
Too much oxygen may be issue in Leigh syndrome
Read More
FDA clears Heat Biologics' IND for study of HS-130 plus HS-110
Read More
